RadMD, a global provider of independent expert physician image reviews for both safety and efficacy endpoints, has entered a partnership with Biomedical Systems, a clinical trial provider to pharmaceutical, medical device, biotech and contract research organizations (CROs).
“We are excited about this partnership as it allows us to fully leverage the significant expertise prevalent in the RadMD organization. Their organization of over 600 experts comprised of Radiologists, Oncologists, Cardiologists, Pathologists, Dermatologists, Gastroenterologists, Wound Healing Experts, Vascular Surgeons, and Medical Imaging Physicists will certainly enable us to provide our clients a superior imaging clinical trial experience. This step forward is particularly important, given the persistent increase in oncology trials and the continued reliance on imaging services for efficacy evaluations. Independent expert readers such as those from RadMD represent a vital component to providing our clients with consistent and reliable data,” said Bob Mills, CCO of Biomedical Systems.
The agreement will enable the 2 organizations to further collaborate on clinical trials and will facilitate a more integrated approach to the execution of the imaging reads. Additionally, this alliance will bolster each organizations’ imaging capabilities, ultimately benefitting sponsors.
“Biomedical Systems has long been known for their dedication to high-quality operations. Their continued growth is a testament to this dedication. The agreement between our organizations establishes a new level of comprehensive reader management by RadMD, leveraging our team of BRITI-certified (BRITI – Blinded Reader and Investigator Training Institute) readers. Our organization will also handle study-specific training and performance management throughout the trial,” said Rick Patt and Kohkan Shamsi, Cofounders and Principals of RadMD. “Further, all of our readers are fellowship-trained disease experts, which is the most critical element of their qualifications. This expertise combined with BMS’ advanced electronic case report forms (eCRFs) will raise the bar on the quality of image interpretations in clinical trials.”
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]